Discover Opportunities

The University of Minnesota Rochester (UMR) inspires transformation in higher education through innovations that empower graduates to solve the grand health challenges of the 21st century. UMR students utilize lab space at One Discovery Square, providing them an opportunity to intersect and synergize with other tenants.

Motion Medical by Boston Scientific formalizes a history of collaboration between medical device manufacturer Boston Scientific and Mayo Clinic. The venture aims to accelerate the development of new minimally invasive treatments for many health conditions that impede quality and longevity of life, including medical technologies for interventional cardiology, heart rhythm management, endoscopy, neuromodulation and urology.

Café Steam is a locally owned, independent coffee shop serving up the best coffees and teas in Rochester. Conveniently located in the atrium of One Discovery Square, Café Steam is committed to supporting businesses in Rochester and throughout Southeastern Minnesota.

Epic develops software to help people get well, help people stay well and help future generations be healthier. Today, more than 250 million patients have a current electronic record in Epic.

Mayo Clinic established the Center for Regenerative Medicine in 2011 to research and develop technologies to repair diseased, injured or congenitally defective tissues and organs – a vital component of medical and surgical practice in the coming years. Efforts in each of the center’s programs, which build on Mayo’s extensive research resources and clinical practice, span the full spectrum of discovery science, translational research and clinical application.

Thermo Fisher Scientific is the world leader in serving science. It takes pride in its mission, which is to enable its customers to make the world healthier, cleaner and safer. It is committed to scientific advancement, offering products and solutions that enable its customers to push the boundaries of innovation in healthcare, life sciences, applied markets, and pharma and biotech.

Philips is a health technology company focused on improving people’s lives through meaningful innovation across the health continuum – from healthy living and prevention to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips partners with customers to deliver integrated solutions that address the Quadruple Aim: improved patient experience, better health outcomes, improved staff experience and lower cost of care.

Exact Sciences is changing the way we think about detecting and treating cancer. As a leader in cancer testing, it is committed to providing earlier answers and life-changing treatment guidance.

Novavita thera, a Cytotheryx company, is a biomedical research company focused on the development of a consistent, high-quality source of human hepatocytes (HHCs) and the application of those HHCs for multiple research and clinical applications.

The Advanced Diagnostics Laboratory, a collaboration between Mayo Clinic’s Department of Laboratory Medicine and Pathology and the Center for Individualized Medicine, increases the pace of innovation by supporting pioneering projects in disruptive technologies, such as multi-omics, artificial intelligence, and digital pathology. It collaborates with tenants in One and Two Discovery Square and elsewhere to increase the lab testing capabilities at Mayo Clinic, accelerate test development in individualized medicine, rapidly implement advanced platforms and technologies, and provide alternate revenue sources.

WuXi Diagnostics chose One Discovery Square for its R&D center – its first U.S.-based location – because of the proximity to Mayo Clinic. WuXi is establishing a next-generation, integrated-diagnostic-enabling platform to improve healthcare practice and advance patient care.

Rion is a clinical-stage regenerative medicine company focused on developing a new type of room temperature stable biologic – exosome therapeutics – that activate the body’s innate ability to heal. Rion’s mission is to develop innovative exosome therapeutics that are clinically impactful and broadly accessible.